CAPR
Price
$26.30
Change
+$0.17 (+0.65%)
Updated
Jan 7, 04:59 PM (EDT)
Capitalization
1.35B
77 days until earnings call
Intraday BUY SELL Signals
KRRO
Price
$8.49
Change
+$0.23 (+2.78%)
Updated
Jan 7 closing price
Capitalization
75.53M
Intraday BUY SELL Signals
Interact to see
Advertisement

CAPR vs KRRO

Header iconCAPR vs KRRO Comparison
Open Charts CAPR vs KRROBanner chart's image
Capricor Therapeutics
Price$26.30
Change+$0.17 (+0.65%)
Volume$40.86K
Capitalization1.35B
Korro Bio
Price$8.49
Change+$0.23 (+2.78%)
Volume$281.42K
Capitalization75.53M
CAPR vs KRRO Comparison Chart in %
CAPR
Daily Signal:
Gain/Loss:
KRRO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CAPR vs. KRRO commentary
Jan 08, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAPR is a Hold and KRRO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 08, 2026
Stock price -- (CAPR: $26.15 vs. KRRO: $8.26)
Brand notoriety: CAPR and KRRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CAPR: 17% vs. KRRO: 15%
Market capitalization -- CAPR: $1.35B vs. KRRO: $75.53M
CAPR [@Biotechnology] is valued at $1.35B. KRRO’s [@Biotechnology] market capitalization is $75.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $113.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAPR’s FA Score shows that 0 FA rating(s) are green whileKRRO’s FA Score has 1 green FA rating(s).

  • CAPR’s FA Score: 0 green, 5 red.
  • KRRO’s FA Score: 1 green, 4 red.
According to our system of comparison, CAPR is a better buy in the long-term than KRRO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAPR’s TA Score shows that 4 TA indicator(s) are bullish while KRRO’s TA Score has 4 bullish TA indicator(s).

  • CAPR’s TA Score: 4 bullish, 6 bearish.
  • KRRO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, KRRO is a better buy in the short-term than CAPR.

Price Growth

CAPR (@Biotechnology) experienced а -9.70% price change this week, while KRRO (@Biotechnology) price change was +4.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.94%. For the same industry, the average monthly price growth was -1.26%, and the average quarterly price growth was +37.65%.

Reported Earning Dates

CAPR is expected to report earnings on Mar 25, 2026.

Industries' Descriptions

@Biotechnology (+1.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CAPR($1.35B) has a higher market cap than KRRO($75.5M). KRRO YTD gains are higher at: 3.121 vs. CAPR (-9.390). CAPR has higher annual earnings (EBITDA): -84.92M vs. KRRO (-89.62M). CAPR has more cash in the bank: 98.6M vs. KRRO (92.5M). CAPR has less debt than KRRO: CAPR (14.5M) vs KRRO (44.7M). CAPR has higher revenues than KRRO: CAPR (11.1M) vs KRRO (7.37M).
CAPRKRROCAPR / KRRO
Capitalization1.35B75.5M1,787%
EBITDA-84.92M-89.62M95%
Gain YTD-9.3903.121-301%
P/E RatioN/AN/A-
Revenue11.1M7.37M151%
Total Cash98.6M92.5M107%
Total Debt14.5M44.7M32%
FUNDAMENTALS RATINGS
CAPR vs KRRO: Fundamental Ratings
CAPR
KRRO
OUTLOOK RATING
1..100
1825
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
12
Undervalued
PROFIT vs RISK RATING
1..100
40100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
3465
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KRRO's Valuation (12) in the null industry is somewhat better than the same rating for CAPR (75) in the Biotechnology industry. This means that KRRO’s stock grew somewhat faster than CAPR’s over the last 12 months.

CAPR's Profit vs Risk Rating (40) in the Biotechnology industry is somewhat better than the same rating for KRRO (100) in the null industry. This means that CAPR’s stock grew somewhat faster than KRRO’s over the last 12 months.

CAPR's SMR Rating (99) in the Biotechnology industry is in the same range as KRRO (100) in the null industry. This means that CAPR’s stock grew similarly to KRRO’s over the last 12 months.

CAPR's Price Growth Rating (34) in the Biotechnology industry is in the same range as KRRO (65) in the null industry. This means that CAPR’s stock grew similarly to KRRO’s over the last 12 months.

CAPR's P/E Growth Rating (100) in the Biotechnology industry is in the same range as KRRO (100) in the null industry. This means that CAPR’s stock grew similarly to KRRO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAPRKRRO
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
72%
MACD
ODDS (%)
Bearish Trend 4 days ago
77%
Bullish Trend 4 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 11 days ago
85%
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
89%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CAPR
Daily Signal:
Gain/Loss:
KRRO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USGRX25.54N/A
N/A
Victory Growth & Income
TSFCX13.14N/A
N/A
Touchstone Small Cap C
JHUJX41.66N/A
N/A
JPMorgan Emerging Markets Equity R2
CRTVX12.26N/A
N/A
Catholic Rsp Invst Mlt-Styl US Eq Inv
FCGYX20.29N/A
N/A
NYLI PineStone Global Equity Class C

CAPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAPR has been loosely correlated with VRAX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CAPR jumps, then VRAX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAPR
1D Price
Change %
CAPR100%
+5.40%
VRAX - CAPR
45%
Loosely correlated
+9.41%
BEAM - CAPR
33%
Loosely correlated
+5.51%
KRRO - CAPR
33%
Loosely correlated
+3.25%
ACLX - CAPR
33%
Poorly correlated
+0.29%
LXEO - CAPR
32%
Poorly correlated
+0.74%
More

KRRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRRO has been loosely correlated with APLT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if KRRO jumps, then APLT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRRO
1D Price
Change %
KRRO100%
+3.25%
APLT - KRRO
58%
Loosely correlated
+4.40%
MGNX - KRRO
44%
Loosely correlated
-0.87%
FULC - KRRO
44%
Loosely correlated
-7.84%
RLAY - KRRO
42%
Loosely correlated
+3.94%
TRDA - KRRO
41%
Loosely correlated
-4.00%
More